Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$8.5 - $12.0 $120,793 - $170,532
-14,211 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$6.99 - $10.6 $27,337 - $41,456
3,911 Added 37.97%
14,211 $129,000
Q1 2020

May 15, 2020

SELL
$3.5 - $7.31 $5,950 - $12,427
-1,700 Reduced 14.17%
10,300 $39,000
Q4 2019

Feb 14, 2020

BUY
$4.6 - $7.88 $55,199 - $94,560
12,000 New
12,000 $93,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $660M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.